FibroGen Inc (FGEN) earnings · rev $6.4M
These earnings events as JSON? API free 100/dayFibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
This FGEN earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported FGEN revenue for 2025-12-31 was $6.4M. Net income was $183.5M. Revenue was down 95.6% from 2023-12-31 to 2025-12-31. FGEN currently screens at market cap $39.3M.
When the next FGEN 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 95.6% from 2023-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full FGEN research stays on the stock page; the tape stays on the quote page.
FGEN earnings FAQ
What are FGEN's latest revenue and net income?
Latest cached FibroGen Inc (FGEN) revenue for Dec 31, 2025 was $6.4M. Net income was $183.5M. Statements: https://lician.com/financials/fgen
What is FGEN's latest diluted EPS?
Latest cached FibroGen Inc (FGEN) diluted EPS for Dec 31, 2025 was $45.38.
What period does the latest FGEN earnings print cover?
The latest cached FibroGen Inc (FGEN) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2023.
How did FGEN revenue change from the prior cached period?
Cached FibroGen Inc (FGEN) revenue was down 95.6% from $147.8M (Dec 31, 2023) to $6.4M (Dec 31, 2025). Statements: https://lician.com/financials/fgen
Where are FGEN earnings listed?
Cached earnings facts for FibroGen Inc (FGEN) are listed at https://lician.com/earnings/fgen. Statements: https://lician.com/financials/fgen
Not investment advice.